Investors
2025 first quarter announcement
We announced our first quarter 2025 results on Wednesday 30 April. Access our first quarter results and latest Annual Report below.
We’re confident in our future
With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Behind the science
Read our latest articles
‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’
‘How do we improve trust in prevention? The answer lies closer to home than you might think’
‘We’re aiming to protect even more children’: Research starts on second-generation malaria vaccine to prevent most severe form of disease
‘Cancer doesn’t have to be a deadly disease – it’s our goal to make it curable’
‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
Vaccinations are not just for children: why adult immunisation is a health and economic necessity
Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk
‘Long-acting therapies are no longer the future of HIV treatment – they are the now’
Is it COVID-19, flu, or RSV? The symptoms to look out for – and how to tell the difference
‘The whooping cough outbreak is a stark reminder of just how important lifelong vaccination is’
